MSTX Looking strong here. Good buying volume suporting a move higher. Maybe the "January effect?" Looking for a continuation for a few days. If it gets near $0.55, I might sell a small portion of holdings to book some profits. If it goes over $0.55 with good volume, i'll hold a portion to see if it continues.
I would love to see us end over $0.50 today?
I expect a lot of resistance near $0.55, the previous high we set in October.
It's getting over bought on the charts now.
From Dec 18th: take this with a grain of salt:
(The never seem to get there very fast, this is longer term. And may never get there.)
Vista Partners announced today that it has updated coverage on Mast Therapeutics Inc. (NYSE MKT: MSTX) ("MSTX"), a publicly traded biopharmaceutical company headquartered in San Diego, CA, with a twelve-month price target of $2.25. Ross Silver, Principal Analyst at Vista Partners, stated, "MSTX began dosing in its pivotal Phase 3 clinical study of MST-188 (purified poloxamer 188) in sickle cell disease in May. MSTX believes that it is currently the only company with a new molecular entity in a Phase 3 clinical trial for the treatment of sickle cell disease, a disease with significant unmet needs and which has been experiencing unprecedented interest from strategic partners, acquisition oriented suitors, and financial investors." Mr. Silver continued, "MSTX plans to develop MST-188 in complications of arterial disease, initially as an adjunct to thrombolytics in acute limb ischemia (ALI), a complication of peripheral arterial disease. Peripheral arterial disease affects an estimated 8 to 12 million people in the United States. The planned Phase 2 trial in ALI is scheduled to commence in the first quarter of 2014." Mr. Silver concludes, "MSTX anticipates that cash as of September 30, 2013 or $0.48/share, should be sufficient to fully fund all planned clinical trials."
